Ming Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ming Ma has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Daniel M. Blumberger
Department of Psychiatry University of Toronto Toronto Ontario Canada
1 shared publication - Jessica U. Ramlakhan
Temerty Centre for Therapeutic Brain Intervention, Division of Mood and Anxiety, Centre for Addiction and Mental Health, Toronto, ON M6J1H4, Canada
1 shared publication - Mera S. Barr
Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada
1 shared publication - Reza Zomorrodi
Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada
1 shared publication - Yoshihiro Noda
Department of Psychiatry, International University of Health and Welfare, Mita Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 28 December 2020
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (1) , 17
The Role of Gamma Oscillations in the Pathophysiology of Substance Use Disorders
Substance use disorders (SUDs) are a major public health problem—with over 200 million people reporting drug use in 2016. Electroencephalography (EEG) is a powerful tool that can provide insights into the impact of SUDs on cognition. Specifically, modulated gamma activity may provide an index of the pathophysiology of SUDs. Thus, the purpose of this review was to investigate the impact of alcohol, tobacco, cannabis, cocaine, and amphetamine on gamma activity, among pre-clinical and clinical populations during acute and chronic exposure and withdrawal states. We searched multiple databases for key terms related to SUDs, EEG, and gamma and ensured rigorous methods by using a standardized review reporting tool. We included 30 studies in this review and found that all substances were associated with modulation of gamma activity, across states and in both preclinical and clinical populations. Gamma oscillations appeared to be differentially modulated in clinical versus preclinical populations and had the most complex relationship with alcohol, indicating that it may act differently than other substances. The findings of this review offer insights into the pathophysiology of SUDs, providing a potential window into novel treatments for SUDs via modulation of gamma activity.
- 28 December 2020
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (1) , 17
Open AccessThe Role of Gamma Oscillations in the Pathophysiology of Substance Use Disorders
Substance use disorders (SUDs) are a major public health problem—with over 200 million people reporting drug use in 2016. Electroencephalography (EEG) is a powerful tool that can provide insights into the impact of SUDs on cognition. Specifically, modulated gamma activity may provide an index of the pathophysiology of SUDs. Thus, the purpose of this review was to investigate the impact of alcohol, tobacco, cannabis, cocaine, and amphetamine on gamma activity, among pre-clinical and clinical populations during acute and chronic exposure and withdrawal states. We searched multiple databases for key terms related to SUDs, EEG, and gamma and ensured rigorous methods by using a standardized review reporting tool. We included 30 studies in this review and found that all substances were associated with modulation of gamma activity, across states and in both preclinical and clinical populations. Gamma oscillations appeared to be differentially modulated in clinical versus preclinical populations and had the most complex relationship with alcohol, indicating that it may act differently than other substances. The findings of this review offer insights into the pathophysiology of SUDs, providing a potential window into novel treatments for SUDs via modulation of gamma activity.